Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers

Pui, 2009, Treatment of childhood acute lymphoblastic leukemia without cranial irradiation., N Engl J Med, 360, 2730, 10.1056/NEJMoa0900386 Mullighan, 2009, Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia., N Engl J Med, 360, 470, 10.1056/NEJMoa0808253 Coustan-Smith, 2009, Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia., Lancet Oncol, 10, 147, 10.1016/S1470-2045(08)70314-0 Pui, 2006, Treatment of acute lymphoblastic leukemia., N Engl J Med, 354, 166, 10.1056/NEJMra052603 Konopleva, 2002, Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins., Leukemia, 16, 1713, 10.1038/sj.leu.2402608 Panayiotidis, 1996, Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro., Br J Haematol, 92, 97, 10.1046/j.1365-2141.1996.00305.x Lagneaux, 1998, Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells., Blood, 91, 2387, 10.1182/blood.V91.7.2387 Burger, 2000, Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1., Blood, 96, 2655, 10.1182/blood.V96.8.2655 Weisberg, 2008, Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells., Mol Cancer Ther, 7, 1121, 10.1158/1535-7163.MCT-07-2331 Manabe, 1994, Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells., Blood, 83, 758, 10.1182/blood.V83.3.758.758 Kumagai, 1996, Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome., J Clin Invest, 97, 755, 10.1172/JCI118474 Iwamoto, 2007, Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase., J Clin Invest, 117, 1049, 10.1172/JCI30235 Mudry, 2000, Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy., Blood, 96, 1926, 10.1182/blood.V96.5.1926 Zeng, 2006, Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias., Mol. Cancer Ther, 5, 3113, 10.1158/1535-7163.MCT-06-0228 Nakata, 2006, Integrin inhibition through Lyn-dependent cross talk from CXCR4 chemokine receptors in normal human CD34+ marrow cells., Blood, 107, 4234, 10.1182/blood-2005-08-3343 Tabe, 2007, Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells., Cancer Res, 67, 684, 10.1158/0008-5472.CAN-06-3166 Hartmann, 2005, CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells., Oncogene, 24, 4462, 10.1038/sj.onc.1208621 Jin, 2008, CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells., Mol Cancer Ther, 7, 48, 10.1158/1535-7163.MCT-07-0042 Streuli, 2009, Signal co-operation between integrins and other receptor systems., Biochem J, 418, 491, 10.1042/BJ20081948 Arcangeli, 2006, Complex functional interaction between integrin receptors and ion channels., Trends Cell Biol, 16, 631, 10.1016/j.tcb.2006.10.003 Arcangeli, 2009, Targeting ion channels in cancer: a novel frontier in antineoplastic therapy., Curr Med Chem, 16, 66, 10.2174/092986709787002835 Sanguinetti, 2006, hERG potassium channels and cardiac arrhythmia., Nature, 440, 463, 10.1038/nature04710 Arcangeli, 2005, Expression and role of hERG channels in cancer cells., Novartis Found Symp, 266, 225 Pillozzi, 2010, Physical and functional interaction between integrins and hERG1 channels in cancer cells., Adv Exp Med Biol, 674, 55, 10.1007/978-1-4419-6066-5_6 Rosenfeld, 1977, Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line., Nature, 267, 841, 10.1038/267841a0 Findley, 1982, Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes., Blood, 60, 1305, 10.1182/blood.V60.6.1305.bloodjournal6061305 Stong, 1985, Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics., Blood, 65, 21, 10.1182/blood.V65.1.21.21 Mihara, 2003, Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase., Br J Haematol, 120, 846, 10.1046/j.1365-2141.2003.04217.x Pillozzi, 2007, VEGFR-1 (FLT-1), beta-1 integrin and hERG K+ channel form a macromolecular signalling complex in acute myeloid leukemia: role in cell migration and clinical outcome., Blood, 110, 1238, 10.1182/blood-2006-02-003772 Schönherr, 1999, Functional role of the slow activation property of ERG K+ channels., Eur J Neurosci, 11, 753, 10.1046/j.1460-9568.1999.00493.x Hara, 2000, Expression of adhesion molecules in childhood B-lineage-cell neoplasms., Int J Hematol, 72, 69 Dürig, 2001, Differential expression of chemokine receptors in B cell malignancies., Leukemia, 15, 752, 10.1038/sj.leu.2402107 Bianchi, 1998, herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells?, Cancer Res, 58, 815 Cherubini, 2005, Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling., Mol Biol Cell, 16, 2972, 10.1091/mbc.e04-10-0940 Bradstock, 2000, Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers., Leukemia, 14, 882, 10.1038/sj.leu.2401729 Masi, 2005, hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines., Br J Cancer, 93, 781, 10.1038/sj.bjc.6602775 Ganapathi, 2009, State-dependent block of HERG potassium channels by R-roscovitine: implications for cancer therapy., Am J Physiol Cell Physiol, 296, C701, 10.1152/ajpcell.00633.2008 Raschi, 2008, The hERG K+ channel: target and antitarget strategies in drug development., Pharmacol Res, 57, 181, 10.1016/j.phrs.2008.01.009 H. Lundbeck A/S Denmark Web site Accessed October 2009 http://www.lundbeck.com/products/Our_products/Serdolect/default.asp Stanat, 2003, Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel., Mol Cell Biochem, 254, 1, 10.1023/A:1027309703313 Rampe, 1998, The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG., J Pharmacol Exp. Ther, 286, 788 Crumb, 2006, Effects of antipsychotic drugs on I(to), I(Na), I(sus), I(K1), and hERG: QT prolongation, structure activity relationship, and network analysis., Pharm Res, 23, 1133, 10.1007/s11095-006-0070-7 Chen, 2005, HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin., Cancer Chemother Pharmacol, 56, 212, 10.1007/s00280-004-0960-5 Bachmann, 2007, Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia., Cancer Res, 67, 4482, 10.1158/0008-5472.CAN-06-4244 Fedyk, 1999, Maturation decreases responsiveness of human bone marrow B lineage cells to stromal-derived factor 1 (SDF-1)., J Leukoc Biol, 66, 667, 10.1002/jlb.66.4.667 Honczarenko, 1999, SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells., Blood, 94, 2990, 10.1182/blood.V94.9.2990 Zhou, 2003, PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells., Cancer Res, 63, 6357 Li, 2009, The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration., Exp Cell Res, 315, 2256, 10.1016/j.yexcr.2009.04.017 Witchel, 2000, Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current., Clin Exp Pharmacol Physiol, 27, 753, 10.1046/j.1440-1681.2000.03337.x Redfern, 2003, Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development., Cardiovasc Res, 58, 32, 10.1016/S0008-6363(02)00846-5